The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
ibudilast zhi liao zhong shu xing xuan yun
Author(s): 
Pages: 251
Year: Issue:  4
Journal: World Clinical Drugs

Keyword:  中枢性眩晕Ibudilast神经耳科学基底动脉供血植物神经眼震眩晕症状脑血流量动物实验椎一基底动脉;
Abstract: <正> 本文对经各项神经耳科学检查诊断为椎-基底动脉供血不足的20例中枢性眩晕患者使用ibudilast(kekas)治疗的效果进行分析。其中男8例,女12例,年龄41~83岁,平均67.8岁。用药方法:本品30mg,分三次单独给与,半数病例根据需要同时给予调节植物神经药物、ATP或镇静剂1~3种。结果,给药后2周内症状消失者5例(占25%),4周以内消失者3例,6周以内3例,8周以上1例,到12周时除1例外,症状均得到改善。4例曾用其他药物治疗无效,改用本品后好转。所有伴随眩晕症状出现的眼震均恢复。Ibudilast是具有扩张血管平滑肌的药物,动物实验证实其增加脑血流量作用比罂
Related Articles
No related articles found